CY1115039T1 - Συνθεση για επαλειψη στο δερμα και χρηση αυτης - Google Patents

Συνθεση για επαλειψη στο δερμα και χρηση αυτης

Info

Publication number
CY1115039T1
CY1115039T1 CY20141100296T CY141100296T CY1115039T1 CY 1115039 T1 CY1115039 T1 CY 1115039T1 CY 20141100296 T CY20141100296 T CY 20141100296T CY 141100296 T CY141100296 T CY 141100296T CY 1115039 T1 CY1115039 T1 CY 1115039T1
Authority
CY
Cyprus
Prior art keywords
skin
oil
composition
leather
treatment
Prior art date
Application number
CY20141100296T
Other languages
English (en)
Inventor
Ali Nahavandi
Original Assignee
Alnapharm Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnapharm Gmbh & Co. Kg filed Critical Alnapharm Gmbh & Co. Kg
Publication of CY1115039T1 publication Critical patent/CY1115039T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Abstract

Η παρούσα εφεύρεση αφορά μια σύνθεση για επάλειψη στο δέρμα, η οποία περιέχει έναν δερματολογικά αποδεκτό φορέα, έλαιο ινδικής καρύδας, φουντουκέλαιο και/ή έλαιο avellana και έλαιο τσουκνίδας, καθώς και την χρήση αυτής για την αντιμετώπιση δερματικών παθήσεων.
CY20141100296T 2011-09-30 2014-04-16 Συνθεση για επαλειψη στο δερμα και χρηση αυτης CY1115039T1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11007992.8A EP2574343B1 (de) 2011-09-30 2011-09-30 Zusammensetzung zum Auftragen auf die Haut und Verwendung derselben

Publications (1)

Publication Number Publication Date
CY1115039T1 true CY1115039T1 (el) 2016-12-14

Family

ID=46851932

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100296T CY1115039T1 (el) 2011-09-30 2014-04-16 Συνθεση για επαλειψη στο δερμα και χρηση αυτης

Country Status (33)

Country Link
US (1) US20140234447A1 (el)
EP (1) EP2574343B1 (el)
JP (1) JP6034386B2 (el)
KR (1) KR101954057B1 (el)
CN (1) CN103841986B (el)
AP (1) AP2014007596A0 (el)
AU (1) AU2012314946B2 (el)
BR (1) BR112014007218B1 (el)
CA (1) CA2848922C (el)
CL (1) CL2014000756A1 (el)
CO (1) CO6930361A2 (el)
CY (1) CY1115039T1 (el)
DK (1) DK2574343T3 (el)
EA (1) EA023746B1 (el)
ES (1) ES2458124T3 (el)
GE (1) GEP20166495B (el)
GT (1) GT201400058A (el)
HK (1) HK1197037A1 (el)
HR (1) HRP20140386T1 (el)
IL (1) IL231589B (el)
MX (1) MX349493B (el)
MY (1) MY184014A (el)
PE (1) PE20141538A1 (el)
PL (1) PL2574343T3 (el)
PT (1) PT2574343E (el)
RS (1) RS53289B (el)
SG (1) SG11201400742PA (el)
SI (1) SI2574343T1 (el)
SM (1) SMT201400051B (el)
TN (1) TN2014000102A1 (el)
UA (1) UA113065C2 (el)
WO (1) WO2013045031A1 (el)
ZA (1) ZA201401941B (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131053A1 (it) * 2013-06-25 2014-12-26 Maria Oliva Salviati Composizione che comprende ortica

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5381612A (en) * 1976-12-24 1978-07-19 Fuarumatsuoiteitsushiyu Fuabur Ointment for treating psoriasis vulgaris * lichen and eczema
DE3232136A1 (de) * 1982-08-28 1984-03-01 Ruth Cegla GmbH, 7542 Schömberg Gemisch enthaltend meersalz und/oder salinensalz
US5165932A (en) * 1987-12-23 1992-11-24 Unipharma Co., Ltd. Therapeutical compositions against psoriasis
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
DE19504914C1 (de) * 1995-02-15 1995-11-16 Goldwell Gmbh Haarwaschmittel
US6752999B2 (en) * 1995-09-20 2004-06-22 Nicholas V. Perricone Method of skin care and/or treatment using lipoic acid
RU2127584C1 (ru) * 1996-02-29 1999-03-20 Коновалов Валерий Николаевич Мазь противовоспалительного, обезболивающего и ранозаживляющего действия (варианты)
RO113110B1 (ro) * 1997-02-13 1998-04-30 Sc Apollo Sa Săpun extrafin
US5997889A (en) * 1998-02-20 1999-12-07 Omnipotent Skin Products, L.L.C. Hand and body creme for the treatment of skin ailments
JP2004500404A (ja) * 2000-03-27 2004-01-08 カール　−　ツァイス　−　シュティフツング 生物活性ガラスを含む新規化粧品、ボディケア、洗浄剤および栄養サプリメント組成物および製造方法およびその使用
US6673756B2 (en) * 2000-09-20 2004-01-06 Symrise Gmbh & Co. Kg Multiphase soaps
ITRM20030204A1 (it) * 2003-04-29 2004-10-30 Provincia Italiana Della Congregazi One Dei Figli Formulazione dermatologica.
US7060306B2 (en) * 2003-11-10 2006-06-13 Springstead Patricia R Skin formulation
US7390507B2 (en) * 2004-04-13 2008-06-24 Ruwart Mary J Compositions and methods for the treatment of radiation burns and other traumatic skin conditions
FR2888497B1 (fr) * 2005-07-13 2010-12-24 Oreal Procede de maquillage et/ou de soin cosmetique
US20080113033A1 (en) * 2006-11-13 2008-05-15 Hrk, Inc. Topical treatment and manufacturing method
DE102007036499A1 (de) * 2007-08-01 2009-02-05 Henkel Ag & Co. Kgaa Naturkosmetisches Haarbehandlungsmittel
FR2956813B1 (fr) * 2010-02-26 2012-07-27 Lea Lab Shampooing et son utilisation

Also Published As

Publication number Publication date
KR20140090985A (ko) 2014-07-18
CO6930361A2 (es) 2014-04-28
HK1197037A1 (en) 2015-01-02
CA2848922C (en) 2020-04-07
MX349493B (es) 2017-08-01
CN103841986A (zh) 2014-06-04
GT201400058A (es) 2015-10-15
AU2012314946B2 (en) 2017-06-15
JP2014527990A (ja) 2014-10-23
RS53289B (en) 2014-08-29
US20140234447A1 (en) 2014-08-21
JP6034386B2 (ja) 2016-11-30
ES2458124T3 (es) 2014-04-30
CN103841986B (zh) 2019-09-03
IL231589A0 (en) 2014-05-28
TN2014000102A1 (en) 2015-07-01
EA201400399A1 (ru) 2014-07-30
BR112014007218A2 (pt) 2017-04-04
HRP20140386T1 (hr) 2014-08-01
CA2848922A1 (en) 2013-04-04
KR101954057B1 (ko) 2019-05-22
PT2574343E (pt) 2014-05-02
UA113065C2 (xx) 2016-12-12
MX2014003846A (es) 2015-01-16
PE20141538A1 (es) 2014-11-18
MY184014A (en) 2021-03-17
SI2574343T1 (sl) 2014-06-30
ZA201401941B (en) 2015-09-30
AP2014007596A0 (en) 2014-04-30
AU2012314946A1 (en) 2014-05-15
PL2574343T3 (pl) 2014-07-31
EA023746B1 (ru) 2016-07-29
DK2574343T3 (da) 2014-04-28
SG11201400742PA (en) 2014-04-28
SMT201400051B (it) 2014-07-07
IL231589B (en) 2019-07-31
EP2574343B1 (de) 2014-01-29
GEP20166495B (en) 2016-06-27
CL2014000756A1 (es) 2014-10-03
NZ623817A (en) 2015-07-31
EP2574343A1 (de) 2013-04-03
WO2013045031A1 (en) 2013-04-04
BR112014007218B1 (pt) 2020-12-15

Similar Documents

Publication Publication Date Title
CY1124311T1 (el) Παρεμποδιστες dna-pk
PE20151495A1 (es) Compuestos de pirrolopirimidina como inhibidores de quinasas
UY35369A (es) Inhibidores quinazolínicos de formas mutadas activantes del receptor del factor de crecimiento epidérmico
PE20121617A1 (es) Derivados de oxazina como inhibidores de bace
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
EA201790273A1 (ru) Флагеллиновые композиции и их применение
TR201901886T4 (tr) DNA-PK inhibitörleri.
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
CR20130550A (es) Ciclopropilaminas como inhibidores de desmetilasa 1 específica de lisina
EA201690513A1 (ru) Комбинация ингибитора mek и ингибитора erk для применения в лечении гиперпролиферативных заболеваний
EA201490423A1 (ru) СПОСОБЫ И КОМПОЗИЦИИ, ОТНОСЯЩИЕСЯ К p62, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ РАКА
ECSP16008797A (es) Derivados de heterobicicloaril como inhibidores rorc2 y métodos de uso de los mismos
NI201500050A (es) Benzamidas
MX2019013808A (es) Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer.
MX2016003823A (es) Inhibidor selectivo de fosfatidil-inositol 3-cinasa-gamma.
EA201591628A1 (ru) Дейтерированный палбоциклиб
UY35747A (es) Derivados sustituidos de fenilalanina
CR20140367A (es) Inhibidores de iap
CY1116234T1 (el) Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
UY35745A (es) Derivados sustituidos de fenilalanina
EA201591507A1 (ru) Лечение рассеянного склероза лахинимодом
CY1116158T1 (el) Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
EA201691130A8 (ru) Средства и способы противодействия миелопролиферативным или лимфопролиферативным расстройствам
EA201491878A1 (ru) Замещенные ксантиновые производные